Source: MarketScreener

Leap Therapeutics: Leap Therapeutics : to Present at Stifel 2020 Healthcare Conference

(marketscreener.com) CAMBRIDGE, Mass., Nov. 10, 2020 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the Stifel 2020 Virtual Healthcare Conference, being held on...https://www.marketscreener.com/quote/stock/LEAP-THERAPEUTICS-INC-33375941/news/Leap-Therapeutics-to-Present-at-Stifel-2020-Healthcare-Conference-31735991/?utm_medium=RSS&utm_content=20201110

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more